Sonoma Pharmaceuticals, Inc. - 8-K Summary
Business Context and Reporting Period
Sonoma Pharmaceuticals, Inc. (Delaware) filed this Current Report on Form 8-K on February 9, 2017. The filing announces the release of financial results for the fiscal quarter ended December 31, 2016.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It serves as a notification that results for the quarter ended December 31, 2016, have been issued.
Guidance, Outlook, and Risks
The report contains forward-looking statements regarding the Company's intentions, beliefs, expectations, and strategies. Management notes that actual outcomes may differ materially due to risks and uncertainties discussed in the Company's Annual Report on Form 10-K. The Company does not undertake an obligation to update these statements except as required by law.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 9, 2017) for specific revenue, net income, and cash flow figures.
- Verify the specific details of the forward-looking statements and associated risk factors referenced in the Form 10-K.
- Confirm the exact date of the press release issuance to ensure alignment with the reporting period.